207 related articles for article (PubMed ID: 38014686)
1. Associations of Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease With Cardiovascular Healthy Outcomes.
Wu W; Ma W; Yuan S; Feng A; Li L; Zheng H; Li S; He N; Huang Y; Lyu J
J Am Heart Assoc; 2023 Dec; 12(23):e031440. PubMed ID: 38014686
[TBL] [Abstract][Full Text] [Related]
2. A healthy lifestyle, Life's Essential 8 scores and new-onset severe NAFLD: A prospective analysis in UK Biobank.
He P; Zhang Y; Ye Z; Li H; Liu M; Zhou C; Yang S; Gan X; Zhang Y; Qin X
Metabolism; 2023 Sep; 146():155643. PubMed ID: 37380018
[TBL] [Abstract][Full Text] [Related]
3. Healthy Lifestyle Is Associated with Reduced Mortality in Patients with Non-Alcoholic Fatty Liver Disease.
Yu C; Gao J; Ge X; Wang X; Ding Y; Tian T; Xu X; Guo W; Wang Q; Ge Z; Jiang T; Zhang Q; Song C
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145163
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort.
Sharma D; Gotlieb N; Farkouh ME; Patel K; Xu W; Bhat M
J Am Heart Assoc; 2022 Jan; 11(1):e022576. PubMed ID: 34927450
[TBL] [Abstract][Full Text] [Related]
5. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease.
Chinnadurai R; Chrysochou C; Kalra PA
Nephron; 2019; 141(1):24-30. PubMed ID: 30384370
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease.
Luo J; Xu L; Li J; Zhao S
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):193-9. PubMed ID: 25563143
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association.
Duell PB; Welty FK; Miller M; Chait A; Hammond G; Ahmad Z; Cohen DE; Horton JD; Pressman GS; Toth PP;
Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):e168-e185. PubMed ID: 35418240
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD).
Chociej AB; Wasilewska N; Flisiak-Jackiewicz M; Lebensztejn D
Curr Pediatr Rev; 2020; 16(4):294-297. PubMed ID: 33038914
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.
Hwang YC; Ahn HY; Park SW; Park CY
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1131-1137.e5. PubMed ID: 29158157
[TBL] [Abstract][Full Text] [Related]
11. Optimizing lifestyle profiles is potential for preventing nonalcoholic fatty liver disease and enhancing its survival.
Tu B; Li W; Xiao H; Xu X; Zhang Y
Sci Rep; 2024 Mar; 14(1):5516. PubMed ID: 38448563
[TBL] [Abstract][Full Text] [Related]
12. Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study.
Song QR; Liu SL; Ling QH; Gao QN; Yang RX; Chen SH; Wu SL; Chen ML; Cai J
Front Endocrinol (Lausanne); 2022; 13():942647. PubMed ID: 36093080
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease (NAFLD) and associated mortality in individuals with type 2 diabetes, pre-diabetes, metabolically unhealthy, and metabolically healthy individuals in the United States.
Golabi P; Paik JM; Kumar A; Al Shabeeb R; Eberly KE; Cusi K; GunduRao N; Younossi ZM
Metabolism; 2023 Sep; 146():155642. PubMed ID: 37380016
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.
Cai J; Zhang XJ; Ji YX; Zhang P; She ZG; Li H
Circ Res; 2020 Feb; 126(5):679-704. PubMed ID: 32105577
[TBL] [Abstract][Full Text] [Related]
15. Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease.
Corey KE; Chalasani N
Clin Gastroenterol Hepatol; 2014 Jul; 12(7):1077-84; quiz e59-60. PubMed ID: 23962548
[TBL] [Abstract][Full Text] [Related]
16. Association of Cardiovascular Risk Factors and Metabolic Syndrome with non-alcoholic and alcoholic fatty liver disease: a retrospective analysis.
Han AL
BMC Endocr Disord; 2021 May; 21(1):91. PubMed ID: 33933056
[TBL] [Abstract][Full Text] [Related]
17. Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk.
Delgado GE; Kleber ME; Moissl AP; Yazdani B; Kusnik A; Ebert MP; März W; Krämer BK; Lammert A; Teufel A
Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G252-G261. PubMed ID: 34132110
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD;
Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212
[TBL] [Abstract][Full Text] [Related]
19. Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).
George ES; Georgousopoulou EN; Mellor DD; Chrysohoou C; Pitsavos C; Panagiotakos DB
Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745097
[TBL] [Abstract][Full Text] [Related]
20. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
